It seems that Newcastle have agreed a deal with PSG to sell Yohan Cabaye for something close to £20M, so he will miss the game on Tuesday night at Norwich City, and as happened three years ago when we sold Andy Carroll to Liverpool for £35M, the race is on to try to buy a replacement before 11:00 pm on Friday night, when the January transfer window closes.
Yohan Cabaye – medical at PSG
Cabaye had traveled with the rest of the Newcastle squad to Norwich ahead of the game at Carrow Road, but the Frenchman will now not play in that game – and will visit Paris tomorrow for a medical.
And his supreme performance in the last game at West Ham, when he scored two fantastic goals turned out to be his last performance for Newcastle – and a fitting one too.
So in case fans didn’t know that every single player at Newcastle has their price, and that money is seemingly all that matters to current owner Mike Ashley – this sale of Newcastle’s best player – again halfway through the season – should make that abundantly clear.
While other clubs much better than Newcastle try to build good teams by buying top players – Newcastle simply try to get top dollar when they sell their best players.
The deal is expected to be completed on Tuesday and now Newcastle will scramble to get a replacement in – and of course other clubs now know Newcastle are flush with £20M, and will ask top dollar for whomever Newcastle are after.
This is what Alan Pardew said about the deal earlier today:
“There’s a price tag on everyone’s head and it needs to be the right price that works for this club”
Notice that this deal will be done before another player was brought in – which shows the priority of Newcastle United under the current leadership – and here’s a hint – it’s not to build a top team.
Ad it seems when a player becomes very good at Newcastle, they are then too good for the club and they are sold for top dollar – and now the question will be who will be next top player to leave Newcastle.
Maybe Yohan’s best friend Mathieu Debuchy in the summer?
Follow us on Twitter, like us on Facebook and +1 on us on Google+